Arguments were underway Thursday in Wilmington, Delaware, in an ANDA patent case involving AET Pharma.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.